Absence of CD26 expression is a useful marker for diagnosis of T-cell lymphoma in peripheral blood - PubMed (original) (raw)
Absence of CD26 expression is a useful marker for diagnosis of T-cell lymphoma in peripheral blood
D Jones et al. Am J Clin Pathol. 2001 Jun.
Abstract
We report flow cytometric characterization of surface CD26 expression in 271 peripheral blood samples from 154 patients evaluated for the presence of a T-cell lymphoproliferative disorder, primarily mycosis fungoides/Sézary syndrome (MF/SS). The presence of morphologically identifiable tumor cells on peripheral blood smears was the criterion for lymphomatous involvement. In 66 of 69 samples from 28 patients, we identified an abnormal CD26-/dim T-cell population that was distinct from the variable CD26 expression seen in normal peripheral blood T cells. This population was CD26- in 23 patients and weakly CD26+ in 5 patients. CD7 was more variably expressed in MF/SS tumor cells, allowing recognition of a distinct, quantifiable abnormal T-cell population in only 34 of 69 involved samples. An increased CD4/CD8 ratio and lower surface expression of CD4 in tumor cells also helped separate the CD26-/dim atypical population for quantification. In 35 blood samples from other types of T-cell tumors, tumor cells in 10 of 11 morphologically involved cases showed absent/dim CD26. Although capable of detecting abnormalities in most cases of MF/SS, CD7 expression does not provide as clear a separation of the neoplastic population and can be replaced by CD26 staining in routine peripheral blood flow cytometric screening of MF/SS patients.
Similar articles
- The usefulness of CD26 in flow cytometric analysis of peripheral blood in Sézary syndrome.
Kelemen K, Guitart J, Kuzel TM, Goolsby CL, Peterson LC. Kelemen K, et al. Am J Clin Pathol. 2008 Jan;129(1):146-56. doi: 10.1309/05GFG3LY3VYCDMEY. Am J Clin Pathol. 2008. PMID: 18089499 - Absence of CD26 expression on skin-homing CLA+ CD4+ T lymphocytes in peripheral blood is a highly sensitive marker for early diagnosis and therapeutic monitoring of patients with Sézary syndrome.
Sokolowska-Wojdylo M, Wenzel J, Gaffal E, Steitz J, Roszkiewicz J, Bieber T, Tüting T. Sokolowska-Wojdylo M, et al. Clin Exp Dermatol. 2005 Nov;30(6):702-6. doi: 10.1111/j.1365-2230.2005.01904.x. Clin Exp Dermatol. 2005. PMID: 16197392 - Association of change in clinical status and change in the percentage of the CD4+CD26- lymphocyte population in patients with Sézary syndrome.
Introcaso CE, Hess SD, Kamoun M, Ubriani R, Gelfand JM, Rook AH. Introcaso CE, et al. J Am Acad Dermatol. 2005 Sep;53(3):428-34. doi: 10.1016/j.jaad.2005.06.001. J Am Acad Dermatol. 2005. PMID: 16112348 - Peripheral blood findings in erythrodermic patients: importance for the differential diagnosis of Sézary syndrome.
Nagler AR, Samimi S, Schaffer A, Vittorio CC, Kim EJ, Rook AH. Nagler AR, et al. J Am Acad Dermatol. 2012 Mar;66(3):503-8. doi: 10.1016/j.jaad.2011.06.014. Epub 2011 Oct 17. J Am Acad Dermatol. 2012. PMID: 22005074 Review. - Flow cytometry for the diagnosis of mycosis fungoides.
Meyerson HJ. Meyerson HJ. G Ital Dermatol Venereol. 2008 Feb;143(1):21-41. G Ital Dermatol Venereol. 2008. PMID: 18833049 Review.
Cited by
- Long-term outcomes of 1,263 patients with mycosis fungoides and Sézary syndrome from 1982 to 2009.
Talpur R, Singh L, Daulat S, Liu P, Seyfer S, Trynosky T, Wei W, Duvic M. Talpur R, et al. Clin Cancer Res. 2012 Sep 15;18(18):5051-60. doi: 10.1158/1078-0432.CCR-12-0604. Epub 2012 Jul 31. Clin Cancer Res. 2012. PMID: 22850569 Free PMC article. - The effect of extracorporeal photopheresis alone or in combination therapy on circulating CD4(+) Foxp3(+) CD25(-) T cells in patients with leukemic cutaneous T-cell lymphoma.
Shiue LH, Couturier J, Lewis DE, Wei C, Ni X, Duvic M. Shiue LH, et al. Photodermatol Photoimmunol Photomed. 2015 Jul;31(4):184-94. doi: 10.1111/phpp.12175. Epub 2015 Mar 28. Photodermatol Photoimmunol Photomed. 2015. PMID: 25772268 Free PMC article. - ATF5 promotes malignant T cell survival through the PI3K/AKT/mTOR pathway in cutaneous T cell lymphoma.
Cao M, Lai P, Liu X, Liu F, Qin Y, Tu P, Wang Y. Cao M, et al. Front Immunol. 2023 Dec 22;14:1282996. doi: 10.3389/fimmu.2023.1282996. eCollection 2023. Front Immunol. 2023. PMID: 38223508 Free PMC article. - CAR-T cell development for Cutaneous T cell Lymphoma: current limitations and potential treatment strategies.
To V, Evtimov VJ, Jenkin G, Pupovac A, Trounson AO, Boyd RL. To V, et al. Front Immunol. 2022 Aug 18;13:968395. doi: 10.3389/fimmu.2022.968395. eCollection 2022. Front Immunol. 2022. PMID: 36059451 Free PMC article. Review. - CD164 and FCRL3 are highly expressed on CD4+CD26- T cells in Sézary syndrome patients.
Wysocka M, Kossenkov AV, Benoit BM, Troxel AB, Singer E, Schaffer A, Kim B, Dentchev T, Nagata S, Ise T, Showe LC, Rook AH. Wysocka M, et al. J Invest Dermatol. 2014 Jan;134(1):229-236. doi: 10.1038/jid.2013.279. Epub 2013 Jun 21. J Invest Dermatol. 2014. PMID: 23792457 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous